Interleukin‐1 Trap Rilonacept Improved Health‐Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODY

BACKGROUND: Recurrent pericarditis is characterized by painful flares and inflammation, which negatively impact health‐related quality of life. RHAPSODY (rilonacept inhibition of interleukin‐1 alpha and beta for recurrent pericarditis: a pivotal symptomatology and outcomes study) evaluated the effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Brucato, Antonio, Lim‐Watson, Michelle Z., Klein, Allan, Imazio, Massimo, Cella, David, Cremer, Paul, LeWinter, Martin M., Luis, Sushil Allen, Lin, David, Lotan, Dor, Pancrazi, Massimo, Trotta, Lucia, Klooster, Brittany, Litcher‐Kelly, Leighann, Zou, Liangxing, Magestro, Matt, Wheeler, Alistair, Paolini, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673658/
https://www.ncbi.nlm.nih.gov/pubmed/36250662
http://dx.doi.org/10.1161/JAHA.121.023252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673658/
https://www.ncbi.nlm.nih.gov/pubmed/36250662
http://dx.doi.org/10.1161/JAHA.121.023252

Ejemplares similares